Suchergebnisse - "Young, Guy"

PubPharm (254)

81

Peripherally inserted central catheters lead to a high risk of venous thromboembolism in children

enthalten in: Blood | 2020

von Jaffray, J. | Witmer, C. | O'Brien, S. | +4

CommentIn: Blood. 2020 Jan 16;135(3):156-157. - PMID 31945150

82

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children : a randomised, controlled, phase 3 trial

enthalten in: The Lancet. Haematology | 2020

von Male, C. | Lensing, A. | Palumbo, J. | +130

CommentIn: Lancet Haematol. 2020 Jan;7(1):e2-e3. - PMID 31699659

83

Health‐related quality of life and caregiver burden of emicizumab in children with haemophilia A and factor VIII inhibitors—Results from the HAVEN 2 study

enthalten in: Haemophilia | 2020

von Mancuso, M. | Mahlangu, J. | Sidonio, R. | +7

84

Comparative validation study of risk assessment models for pediatric hospital‐acquired venous thromboembolism

enthalten in: Journal of Thrombosis and Haemostasis | 2020

von Mahajerin, A. | Jaffray, J. | Branchford, B. | +5

85

Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein‐Jr phase 3 dose‐exposure‐response evaluation

enthalten in: Journal of Thrombosis and Haemostasis | 2020

von Young, G. | Lensing, A. | Monagle, P. | +25

86

Neutralizing antidrug antibody to emicizumab in a patient with severe hemophilia A with inhibitors : New case with detailed laboratory evaluation

enthalten in: Journal of Thrombosis and Haemostasis | 2020

von Harkins Druzgal, C. | Kizilocak, H. | Brown, J. | +2

87

Implications of the first FDA‐approved anticoagulant in pediatrics : One ship has sailed but the next ones are at the dock

enthalten in: Pediatric Blood & Cancer | 2020

von Young, G.

88

The Edoxaban Hokusai VTE PEDIATRICS Study : An open‐label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic disease

enthalten in: Research and Practice in Thrombosis and Haemostasis | 2020

von Ommen, C. | Albisetti, M. | Chan, A. | +7

89

Nonacog beta pegol (N9‐GP) in hemophilia B : First report on safety and efficacy in previously untreated and minimally treated patients

enthalten in: Research and Practice in Thrombosis and Haemostasis | 2020

von Chan, A. | Alamelu, J. | Barnes, C. | +4

90

A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors

enthalten in: Blood | 2019

von Young, G. | Liesner, R. | Chang, T. | +13